إعلان
إعلان
MNPR
Monopar Therapeutics Inc. Common Stock
62.74
USDبرعاية
-0.66
-1.03%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
63.19
+0.45
+0.71%
تقارير أرباح MNPR
النسبة الإيجابية المفاجئة
MNPR تفوق 15 من 24 آخر التقديرات.
63%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.47
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-2.08%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-82.91%
Monopar Therapeutics Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, MNPR reported earnings of -0.48 USD per share (EPS) for Q3 25, missing the estimate of -0.43 USD, resulting in a -9.44% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.36% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 المحللين forecast an EPS of -0.47 USD, with revenue projected to reach -- USD, implying an نقصان of -2.08% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Monopar Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Monopar Therapeutics Inc. Common Stock reported EPS of -$0.48, missing estimates by -9.44%, and revenue of $0.00, 0% as expectations.
How did the market react to Monopar Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 5.36%, changed from $82.58 before the earnings release to $87.01 the day after.
When is Monopar Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Monopar Therapeutics Inc. Common Stock's next earnings report?
Based on 15
المحللين, Monopar Therapeutics Inc. Common Stock is expected to report EPS of -$0.47 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان